Jeremy S. Caldwell

Jeremy S. Caldwell

Vorstandsvorsitzender bei Jengu Therapeutics, Inc.

55 Jahre
Health Technology
Commercial Services
Finance

Profil

Jeremy S.
Caldwell
is the founder of Kalypsys, Inc. (founded in 2001).
He is currently the Chief Executive Officer & Director at Jengu Therapeutics, Inc., a Director at Odyssey Thera, Inc., a Member of the American Society for Microbiology, and a Member of the Society for Biomolecular Screening, Inc. He is also a Partner at Red Tree Venture Capital (starting in 2023) and the Chief Executive & Financial Officer, Secretary at Light Horse Therapeutics, Inc. Dr. Caldwell previously served as the President and Chief Executive Officer of Mistral Therapeutics, Inc. in 2018, the President, Chief Executive Officer & Director of Inception Sciences, Inc. from 2018 to 2023, and the Executive Director & Head-Technology & Research at Novartis Institute for Functional Genomics, Inc. He has also held positions as a Director at Chinook Therapeutics, Inc., a Board of Directors member at Chinook Therapeutics U.S., Inc., Lycia Therapeutics, Inc., and Belharra Therapeutics, Inc., and a Project Leader at Rigel Pharmaceuticals, Inc. Dr. Caldwell was a Venture Partner at Versant Venture Management LLC from 2018 to 2023 and an Entrepreneur-in-Residence at Third Rock Ventures LLC.
He served as the Vice President of Merck Research Laboratories Massachusetts LLC from 2008 to 2013 and as the Chief Scientific Officer & Executive VP at Ardelyx, Inc. from 2014 to 2018.
Dr. Caldwell holds a doctorate degree from Stanford University (conferred in 1997) and an undergraduate degree from the University of California, Berkeley (conferred in 1991).

Aktive Positionen von Jeremy S. Caldwell

UnternehmenPositionBeginn
Direktor/Vorstandsmitglied -
Society for Biomolecular Screening, Inc. Corporate Officer/Principal -
Corporate Officer/Principal -
Vorstandsvorsitzender -
Private Equity Investor 01.10.2023
Alle aktiven Positionen von Jeremy S. Caldwell

Ehemalige bekannte Positionen von Jeremy S. Caldwell

UnternehmenPositionEnde
Private Equity Investor 01.10.2023
Vorstandsvorsitzender 01.10.2023
Direktor/Vorstandsmitglied 01.10.2023
Direktor/Vorstandsmitglied 01.09.2021
░░░░░░░ ░░░░░░░░░░░░ ░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Jeremy S. Caldwell im Detail an

Ausbildung von Jeremy S. Caldwell

Stanford University Doctorate Degree
University of California, Berkeley Undergraduate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Jeremy S. Caldwell im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

21

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen2
RIGEL PHARMACEUTICALS, INC.

Health Technology

ARDELYX, INC.

Health Technology

Private Unternehmen17

Health Technology

Health Technology

Finance

Health Technology

Commercial Services

Health Technology

Commercial Services

Commercial Services

Society for Biomolecular Screening, Inc.

Health Technology

Commercial Services

Technology Services

Health Technology

Finance

Health Technology

Health Services

Finance

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Jeremy S. Caldwell